Claris Advisors’s Teladoc Health TDOC Stock Holding History

Claris Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$46	–	1027
2024 Q3	$46	Buy	+5	New	+$41	﹤0.01%	1200

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Claris Advisors's TDOC Position: Q4 2024 in Review

Claris Advisors sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 5 shares — an estimated $46 sold.

Claris Advisors first reported a position in TDOC in Q3 2024 and held it in 1 quarter. The position peaked at $46 in Q3 2024. 380 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

Claris Advisors reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
Claris Advisors sold 5 Teladoc Health shares in Q4 2024, an estimated $46.
Claris Advisors first reported a position in Teladoc Health in Q3 2024 and held it in 1 quarter.
Claris Advisors's Teladoc Health position peaked at $46 in Q3 2024.
380 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.